Business Standard

Dr Reddys Laboratories Share Price

Know More
BSENSE

1,246.30 3.55 (0.29%)

04:00 PM, 13-Dec-2024

1,246.35 0.95 (0.08%)

03:49 PM, 13-Dec-2024

BSE : 500124

NSE : DRREDDY

Sector : Health care

ISIN Code : INE089A01031

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 13-Dec-2024 | 04:00 PM IST

Market Cap (₹ Cr)

1,03,991

Traded Value (₹ Cr)

8.40

Volume (Shares)

67,415

Face Value (₹)

1

52-Week High (₹)

1,420.20

52-Week High Date

21-Aug-2024

52-Week Low (₹)

1,094.88

52-Week Low Date

21-Dec-2023

All Time High (₹)

1,420.20

All Time High Date

21-Aug-2024

All Time Low (₹)

0.77

All Time Low Date

11-Jun-1990

Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs) custom pharmaceutical services generics biosimilars and differentiated formulations. The company's major therapeutic areas of focus are gastrointestinal cardiovascular diabetology oncology pain management and dermatology. Dr. Reddy's operates in markets across the globe. Its major markets include - USA India Russ...
Read More

Dr Reddy's Labs News

Kazakhstan authority imposes penalty of Rs 28.7 lakh on Dr Reddy's unit

1 min read

Dr. Reddy's up 2% on launching Toripalimab to treat nasopharyngeal cancer

2 min read

Dr Reddy's launches Toripalimab to treat nasopharyngeal cancer in India

3 min read

Dr Reddy's Labs tanks over 3% after USFDA inspects Hyderabad API facility

2 min read

USFDA issues seven observations to Dr Reddy's Hyderabad manufacturing plant

1 min read

Dr Reddy's earnings future uncertain beyond FY27, say analysts; stock up 3%

3 min read
More

Dr Reddys Laboratories Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,03,995

EPS - TTM (₹) [C]

63.98

P/E Ratio (X) [C]

19.48

Face Value (₹) 1
Latest Dividend (%)800.00
Latest Dividend Date 16-Jul-2024
Dividend Yield (%) 0.64
Book Value Share (₹) [C]368.52
P/B Ratio (₹) [C]3.38

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
SBI Nifty 50 ETF 1350.97 1,12,36,556 0.68
Parag Parikh Flexi Cap Fund (G) 837.42 69,65,116 0.99
Parag Parikh Flexi Cap Fund - Direct (G) 837.42 69,65,116 0.99
ICICI Pru Value Discovery Fund (G) 691.11 57,48,252 1.41
ICICI Pru Value Discovery Fund (IDCW) 691.11 57,48,252 1.41
ICICI Pru Value Discovery Fund - Direct (G) 691.11 57,48,252 1.41
ICICI Pru Value Discovery Fund - Direct (IDCW) 691.11 57,48,252 1.41
Nippon India Large Cap Fund (G) 573.19 47,67,429 1.62
Nippon India Large Cap Fund (IDCW) 573.19 47,67,429 1.62
Nippon India Large Cap Fund (Bonus) 573.19 47,67,429 1.62

Load more

Research Reports

DateBrokerActionPrices(₹) Report
29-Jul-2024Edelweiss Securities Underperform 6,237
02-Apr-2024Share Khan Buy 6,537
30-Oct-2023Prabhudas Lilladher Reduce 5,300
26-May-2023Anand Rathi Not Rated -
12-May-2023Prabhudas Lilladher Reduce 4,500

Stock Strength

Today's Low/High (₹)

1,226.45

1,250.20

Week Low/High (₹)

1,226.35

1,262.00

Month Low/High (₹)

1,170.20

1,265.00

Year Low/High (₹)

1,094.24

1,421.00

All time Low/High (₹)

0.77

1,421.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.58%-0.59%0.520.37%
1 Month0.05%0.11%5.725.13%
3 Month-6.41%-6.44%-0.91-2.32%
6 Month2.24%2.23%6.935.85%
1 Year11.40%11.31%18.0318.36%
3 Year35.52%35.48%40.9242.61%

Company Info

Company Information

Co-Chairman & Managing Directo : G V Prasad

Executive Chairman : K Satish Reddy

Independent Director : Shikha Sanjaya Sharma

Lead Independent Director : Leo Puri

Independent Director : K P Krishnan

Independent Director : Pennv Wan

Company Sec. & Compli. Officer : K Randhir Singh

Independent Director : Arun M. Kumar

Independent Director : Claudio Albrecht

Independent Director : Sanjiv Mehta

Independent Director : Alpna Seth

Registered Office: 8-2-337 Road No 3, Banjara Hills,Hyderabad,Telangana-500034 Ph: 91-40-49002900

Email:shares@drreddys.com; mail@drreddys.com

URL:http://www.drreddys.com

FAQs about Dr Reddys Laboratories Ltd

1. What's the Dr Reddys Laboratories Ltd share price today?
Dr Reddys Laboratories Ltd share price was Rs 1,246.30 at 04:00 PM IST on 13th Dec 2024. Dr Reddys Laboratories Ltd share price was up by 0.29% over the previous closing price of Rs 1,242.75. Dr Reddys Laboratories Ltd share price trend:

  • Last 1 Month: Dr Reddys Laboratories Ltd share price moved up by 0.05% on BSE
  • Last 3 Months: Dr Reddys Laboratories Ltd share price moved down by 6.41% on BSE
  • Last 12 Months: Dr Reddys Laboratories Ltd share price moved up by 11.40% on BSE
  • Last 3 Years: Dr Reddys Laboratories Ltd price moved up by 35.52% on BSE


2. How can I quickly analyse the performance of the Dr Reddys Laboratories Ltd stock?
The performance of the Dr Reddys Laboratories Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 19.48
  • Price to book value ratio is 3.38
  • Dividend yield of 0.64
  • The EPS (trailing 12 months) of the Dr Reddys Laboratories Ltd stock is Rs 63.98


3. What is the market cap of Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd has a market capitalisation of Rs 1,03,991 crore.


4. What is Dr Reddys Laboratories Ltd's 52-week high/low share price?
The Dr Reddys Laboratories Ltd’s 52-week high share price is Rs 1,420.20 and 52-week low share price is Rs 1,094.88.


5. Is the Dr Reddys Laboratories Ltd profitable?
On a consolidated basis, Dr Reddys Laboratories Ltd reported a profit of Rs 1,882.10 crore on a total income of Rs 6,903.90 crore for the quarter ended 2024. For the year ended Sep 2024, Dr Reddys Laboratories Ltd had posted a profit of Rs 1,341.90 crore on a total income of Rs 8,351.80 crore.


6. Which are Dr Reddys Laboratories Ltd’s peers in the Health care sector?
Dr Reddys Laboratories Ltd’s top 5 peers in the Health care sector are Cipla, Torrent Pharma., Mankind Pharma, Dr Reddy's Labs, Zydus Lifesci., Lupin, Aurobindo Pharma.


7. Who owns how much in Dr Reddys Laboratories Ltd?
Key changes to the Dr Reddys Laboratories Ltd shareholding are as follows:

  • Promoter holding in Dr Reddys Laboratories Ltd has gone down to 26.64 per cent as of Sep 2024 from 26.65 per cent as of Dec 2023.